Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma
Clinical trial NCT07450508 · COMPLETED
Trial details
- NCT number
- NCT07450508
- Sponsor
- Cairo University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2024-10-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.